---
type: log
status: active
sources:
  - user input, 2026-06-14
created: 2026-06-14
updated: 2026-06-14
---

# MirrorSoft Log

## 2026-06-14 | initialize | create Nadeln workspace for MirrorSoft

- Sources:
  - User input, 2026-06-14
- Changed:
  - `projects/Nadeln/README.md`
  - [[project-brief]]
  - [[sources]]
  - [[log]]
- Notes:
  - Created a dedicated company/product workspace for MirrorSoft and atraumatic premium cannulas.
  - No company URL, product documents, or external sources have been ingested yet.
  - Marked all product, market, customer, competitor, medical, and regulatory claims as requiring verification until sources are added.

## 2026-06-14 | ingest | register MirrorSoft official website

- Sources:
  - https://mirrorsoft.de/
  - https://promamedical.de/
  - https://promainject.com/Mirror-Soft-Stumpfe-Kanuelen
- Changed:
  - [[index]]
  - [[project-brief]]
  - [[mirrorsoft-website-summary]]
  - [[mirrorsoft-company-context]]
  - [[sources]]
  - [[log]]
  - `projects/Nadeln/README.md`
- Notes:
  - Registered the official MirrorSoft website and related PromaMedical / PromaInject pages as the first company/product evidence.
  - Created a first source summary and cautious company-context page.
  - At this stage, datasheet links were assumed from the website structure but had not yet been verified or saved locally.
  - Medical, safety, regulatory, and market claims remain verification-sensitive.

## 2026-06-14 | synthesize | create MirrorSoft context dossier v0.1

- Sources:
  - https://mirrorsoft.de/
  - https://promamedical.de/
  - https://promainject.com/Mirror-Soft-Stumpfe-Kanuelen
  - [[mirrorsoft-website-summary]]
  - [[mirrorsoft-company-context]]
- Changed:
  - [MirrorSoft Context Dossier v0.1](_outputs/mirrorsoft-context-dossier-v0-1.md)
  - [[index]]
  - [[sources]]
  - [[log]]
- Notes:
  - Created the first structured working dossier.
  - Separated sourced website claims from analysis hypotheses and verification needs.
  - Recommended source-pack completion before strategy or sales copy development.

## 2026-06-14 | ingest | secure and evaluate MirrorSoft data sheet evidence

- Sources:
  - `raw/mirrorsoft-official-website-2026-06-14.html`
  - `raw/mirrorsoft-official-website-2026-06-14-extracted-text.txt`
  - `raw/assets/mirror-soft-atraumatische-kanuele-digital-large.png`
  - `raw/assets/mirror-soft-atraumatische-kanuele-jcd-publikation-radke-et-al.png`
  - `raw/assets/mirror-soft-atraumatische-kanuele-verpackung-variante-digital.png`
  - `raw/assets/mirror-soft-atraumatische-kanuele-innovation.png`
  - `raw/pmc12648355-electron-microscopy-study.html`
  - `raw/pmc12945863-reply-needle-clogging.html`
- Changed:
  - [[mirrorsoft-datenblatt-und-belege-auswertung]]
  - [MirrorSoft Context Dossier v0.2](_outputs/mirrorsoft-context-dossier-v0-2.md)
  - [[index]]
  - [[mirrorsoft-company-context]]
  - [[mirrorsoft-website-summary]]
  - [[sources]]
  - [[log]]
- Notes:
  - No direct PDF datasheet link was found in the static MirrorSoft website source.
  - Secured the embedded website data sheet as raw HTML and extracted text.
  - Secured relevant product/evidence images and both cited PMC articles.
  - Flagged patient safety, infection-risk, EMA-standard, price superiority, and clinical-performance claims as requiring claim review before external use.

## 2026-06-14 | synthesize | create MirrorSoft claim matrix v0.1

- Sources:
  - [[mirrorsoft-datenblatt-und-belege-auswertung]]
  - `raw/mirrorsoft-official-website-2026-06-14-extracted-text.txt`
  - `raw/pmc12648355-electron-microscopy-study.html`
  - `raw/pmc12945863-reply-needle-clogging.html`
- Changed:
  - [MirrorSoft Claim Matrix v0.1](_outputs/mirrorsoft-claim-matrix-v0-1.md)
  - [[index]]
  - [[sources]]
  - [[log]]
- Notes:
  - Classified exact MirrorSoft claims by source, evidence strength, risk, and allowed use.
  - Marked infection-risk, patient-safety, clinical-superiority, EMA-standard, price-superiority, and broad comparative claims as requiring claim review or not externally usable yet.
  - Identified safer wording territories for internal strategy and careful marketing development.

## 2026-06-14 | synthesize | create MirrorSoft framework fit v0.1

- Sources:
  - [MirrorSoft Claim Matrix v0.1](_outputs/mirrorsoft-claim-matrix-v0-1.md)
  - [MirrorSoft Context Dossier v0.2](_outputs/mirrorsoft-context-dossier-v0-2.md)
  - `../../../../wiki/messaging-frameworks.md`
  - `../../../../wiki/brand-system.md`
  - `../../../../wiki/b2b-persona-development.md`
  - `../../../../wiki/customer-journey-mapping.md`
  - `../../../../wiki/campaign-types-and-funnel-stages.md`
  - `../../../../wiki/account-based-marketing.md`
  - `../../../../wiki/marketing-strategy-library.md`
  - `../../../../wiki/marketing-sales-and-buyer-enablement-library.md`
  - `../../../../wiki/briefing-system.md`
  - `../../../../wiki/ai-research-validation.md`
- Changed:
  - [MirrorSoft Framework Fit v0.1](_outputs/mirrorsoft-framework-fit-v0-1.md)
  - [[index]]
  - [[sources]]
  - [[log]]
- Notes:
  - Recommended Claim Matrix / Evidence Validation, Messaging + Brand System, B2B Persona Development, Customer Journey Mapping, and Campaign Types/Funnel Stages as the first framework stack.
  - Held ABM, Sales/Buyer Enablement, Briefing System, and OGSM/Marketing Strategy Library for later use once target market, accounts, and commercial objective are clearer.
  - Recommended approved claim language as the next concrete step before positioning or persona work.

## 2026-06-14 | synthesize | create MirrorSoft approved claim language v0.1

- Sources:
  - [MirrorSoft Claim Matrix v0.1](_outputs/mirrorsoft-claim-matrix-v0-1.md)
  - [MirrorSoft Framework Fit v0.1](_outputs/mirrorsoft-framework-fit-v0-1.md)
  - [[mirrorsoft-datenblatt-und-belege-auswertung]]
- Changed:
  - [MirrorSoft Approved Claim Language v0.1](_outputs/mirrorsoft-approved-claim-language-v0-1.md)
  - [[index]]
  - [[sources]]
  - [[log]]
- Notes:
  - Created three wording tiers: internal only, careful external draft, and blocked pending review.
  - Added conservative product/category, design, flow, packaging, evidence, and caveat wording.
  - Preserved red-flag exclusions for clinical superiority, infection prevention, guaranteed no-clogging, EMA claims, and unbenchmarked price superiority.

## 2026-06-14 | synthesize | integrate subagent findings and create message house v0.1

- Sources:
  - [MirrorSoft Approved Claim Language v0.1](_outputs/mirrorsoft-approved-claim-language-v0-1.md)
  - [MirrorSoft Claim Matrix v0.1](_outputs/mirrorsoft-claim-matrix-v0-1.md)
  - [MirrorSoft Framework Fit v0.1](_outputs/mirrorsoft-framework-fit-v0-1.md)
  - Subagent reports, 2026-06-14
- Changed:
  - [Subagent Source Evidence Benchmark Synthesis](_outputs/subagent-source-evidence-benchmark-synthesis-2026-06-14.md)
  - [MirrorSoft Message House v0.1](_outputs/mirrorsoft-message-house-v0-1.md)
  - [[index]]
  - [[sources]]
  - [[log]]
- Notes:
  - Integrated findings from Evidence & Source Scout, Medical Literature Reviewer, and Competitor & Price Benchmark Scout.
  - Direct EN/DE PDF leads returned 404 on direct retrieval and remain unresolved source leads.
  - Created a proof-led message house that stays within the approved claim language and avoids clinical/regulatory overreach.
  - Recommended persona hypotheses as the next strategic output.

## 2026-06-14 | synthesize | create MirrorSoft persona hypotheses v0.1

- Sources:
  - [MirrorSoft Message House v0.1](_outputs/mirrorsoft-message-house-v0-1.md)
  - [MirrorSoft Approved Claim Language v0.1](_outputs/mirrorsoft-approved-claim-language-v0-1.md)
  - [MirrorSoft Framework Fit v0.1](_outputs/mirrorsoft-framework-fit-v0-1.md)
  - [Subagent Source Evidence Benchmark Synthesis](_outputs/subagent-source-evidence-benchmark-synthesis-2026-06-14.md)
- Changed:
  - [MirrorSoft Persona Hypotheses v0.1](_outputs/mirrorsoft-persona-hypotheses-v0-1.md)
  - [[index]]
  - [[sources]]
  - [[log]]
- Notes:
  - Created first role-based persona hypotheses: aesthetic injector, practice owner / clinic lead, purchasing / operations, distributor / reseller, and trainer / KOL.
  - Marked all personas as hypotheses pending customer, sales, distributor, or market validation.
  - Recommended customer journey mapping as the next strategic output.

## 2026-06-14 | synthesize | create MirrorSoft customer journey map v0.1

- Sources:
  - [MirrorSoft Persona Hypotheses v0.1](_outputs/mirrorsoft-persona-hypotheses-v0-1.md)
  - [MirrorSoft Message House v0.1](_outputs/mirrorsoft-message-house-v0-1.md)
  - [MirrorSoft Approved Claim Language v0.1](_outputs/mirrorsoft-approved-claim-language-v0-1.md)
  - [MirrorSoft Framework Fit v0.1](_outputs/mirrorsoft-framework-fit-v0-1.md)
  - [Subagent Source Evidence Benchmark Synthesis](_outputs/subagent-source-evidence-benchmark-synthesis-2026-06-14.md)
- Changed:
  - [MirrorSoft Customer Journey Map v0.1](_outputs/mirrorsoft-customer-journey-map-v0-1.md)
  - [[index]]
  - [[sources]]
  - [[log]]
- Notes:
  - Created a role-based customer journey across awareness, consideration, evaluation, purchase/trial, and adoption.
  - Kept all journey assumptions hypothesis-driven and evidence-sensitive.
  - Identified IFU, documentation, PDF datasheet resolution, product master data, and structured user feedback as priority gaps.
  - Recommended an evidence pack outline as the next strategic output.

## 2026-06-14 | synthesize | create MirrorSoft evidence pack outline v0.1

- Sources:
  - [MirrorSoft Customer Journey Map v0.1](_outputs/mirrorsoft-customer-journey-map-v0-1.md)
  - [MirrorSoft Claim Matrix v0.1](_outputs/mirrorsoft-claim-matrix-v0-1.md)
  - [MirrorSoft Approved Claim Language v0.1](_outputs/mirrorsoft-approved-claim-language-v0-1.md)
  - [MirrorSoft Persona Hypotheses v0.1](_outputs/mirrorsoft-persona-hypotheses-v0-1.md)
  - [Subagent Source Evidence Benchmark Synthesis](_outputs/subagent-source-evidence-benchmark-synthesis-2026-06-14.md)
- Changed:
  - [MirrorSoft Evidence Pack Outline v0.1](_outputs/mirrorsoft-evidence-pack-outline-v0-1.md)
  - [[index]]
  - [[sources]]
  - [[log]]
- Notes:
  - Created an evidence inventory covering product identity, technical design, scientific evidence, regulatory documentation, commercial evidence, and practitioner feedback.
  - Separated minimum evidence pack v1 from expanded evidence pack v2.
  - Listed immediate evidence requests for IFU, datasheets, certificates, labels, product master data, price/channel details, and user feedback.
  - Recommended an interview and trial feedback guide as the next output.
